MedTrace Logo

Pay-it-forward RCT for Gonorrhea and Chlamydia Testing

NCT03741725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 301

Last updated 2020-07-07

Study results available
· View outcomes & findings →

Summary

This is a randomized controlled trial which will evaluate dual gonorrhea/chlamydia test uptake and other outcomes in men who have sex with men (MSM) in three trial arms - 1) a pay-it-forward testing arm, 2) a pay-what-you-want testing arm, and 3) standard of care arm.

Conditions

  • Gonorrhea Male
  • Chlamydia;M

Interventions

OTHER

Pay-it-forward

Participants will be offered a gift of free gonorrhea and chlamydia testing made available by donations from previous testers, and asked whether they would like to donate money (pay-it-forward) for future men to receive the same option.

OTHER

Pay-what-you-want

Participants will be offered gonorrhoea and chlamydia testing and told that they can decide and pay any desired amount after receiving the test.

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • National Institute on Aging (NIA)

    collaborator NIH

  • Southern Medical University, China

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Social Entrepreneurship to Spur Health

    collaborator OTHER

  • Yale University

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Joseph D Tucker, MD, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-08
Primary Completion
2019-09-02
Completion
2019-09-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03741725 on ClinicalTrials.gov